Discontinued — last reported Q4 '22
Other
Short-term debt and current portion of long-term debt
Gilead Sciences Short-term debt and current portion of long-term debt decreased by 53.2% to $1.31B in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ4 2015
Last reportedQ4 2022
How to read this metric
Lower levels reduce immediate liquidity pressure, while high levels may signal a need for refinancing or significant cash outflows.
Detailed definition
The portion of total debt obligations, including bank loans and notes, that is due for repayment within the next twelve...
Peer comparison
A key indicator of short-term financial health compared to peers with similar capital structures.
Metric ID:
other_debt_currentHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $2.81B | $1.31B |
| QoQ Change | — | -53.2% |
Range$1.31B – $2.81B
Short-term debt and current portion of long-term debt at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's short-term debt and current portion of long-term debt?
- Gilead Sciences (GILD) reported short-term debt and current portion of long-term debt of $1.31B in Q1 2026.
- What does short-term debt and current portion of long-term debt mean?
- The amount of debt that must be paid back within one year.